Kristin Stephens

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristin Stephens:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Chief Development Officer Common Stock 0 $0 $0.2200 18 Nov 2024 Direct
Syros Pharmaceuticals, Inc. Chief Development Officer Restricted Stock Units 0 $0 $2.10 31 Oct 2024 Direct

Insider Reports Filed by Kristin Stephens

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRS Syros Pharmaceuticals, Inc. 18 Nov 2024 1 -$7,949 4 Chief Development Officer 20 Nov 2024, 17:00
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2024 3 -$12,757 4 Chief Development Officer 04 Nov 2024, 17:00
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2024 5 -$21,596 4 Chief Development Officer 02 Apr 2024, 17:01
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2023 3 -$12,601 4 Chief Development Officer 02 Nov 2023, 16:52
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2023 3 -$1,607 4 Chief Development Officer 04 Apr 2023, 18:55
SYRS Syros Pharmaceuticals, Inc. 16 Feb 2023 1 $0 4 Chief Development Officer 21 Feb 2023, 15:27
SYRS Syros Pharmaceuticals, Inc. 06 Oct 2022 2 $0 4 Chief Development Officer 11 Oct 2022, 16:39
SYRS Syros Pharmaceuticals, Inc. 01 Apr 2022 1 -$15,809 4 Chief Development Officer 04 Apr 2022, 17:04
SYRS Syros Pharmaceuticals, Inc. 15 Feb 2022 3 $0 4 Chief Development Officer 17 Feb 2022, 15:08
SYRS Syros Pharmaceuticals, Inc. 08 Jun 2021 0 $0 3 Chief Development Officer 10 Jun 2021, 17:23